BUPA - the personal health service
  

search 

home

products &
services

health
information

facilities
finder

about
BUPA

jobs
at BUPA

contact
BUPA

Products and services

Health insurance

Financial protection

Care homes

Health assessments

Childcare

Travel insurance

International cover

Cash plans

Shop

Visitor interest areas

Individuals

Business

Intermediaries

Health professionals

BUPA members

Facilities finder

Find local health and fitness facilities

World of BUPA

BUPA services around the world at bupa.com

    

home  |  health information  |  health factsheets

Print-friendly version [opens in a new window]

Chronic leukaemia

Published by BUPA's health information team, healthinfo@bupa.com, February 2008.

This factsheet is for people who have chronic leukaemia, or who would like information about it.

Chronic leukaemia is a cancer of the blood that develops slowly. There are two main types of chronic leukaemia, depending on the type of cells affected: chronic lymphocytic leukaemia (CLL) or chronic myeloid leukaemia (CML).

About chronic leukaemia

The term leukaemia refers to a group of cancers of the blood cells. In leukaemia, white blood cells become abnormal, and divide and grow in an uncontrolled way. There are two main types of leukaemia: acute leukaemia and chronic leukaemia. For more information about leukaemia in general, please see Related topics.

According to Cancer Research UK, 3,000 people are diagnosed with chronic leukaemia each year. This accounts for around 1 percent of newly diagnosed cancers in the UK.

Chronic leukaemia tends to develop slowly, over many months or years.

Types of chronic leukaemia

There are two types of chronic leukaemia, depending on the type of white blood cells affected. The bone marrow produces two main types of white blood cells - lymphocytes and myelocytes - which work together to fight off infections. These two main types of acute leukaemia are as follows.

Chronic lymphocytic leukaemia (CLL)

This type is where there are abnormal cells in your bone marrow, which mature into slightly abnormal lymphocytes in the bloodstream that don't work properly and live longer than normal lymphocytes. CLL is the most common type of leukaemia. It's most common in people over 60, and is rare in people under 40.

Chronic myeloid leukaemia (CML)

This type is where there are abnormal cells in your bone marrow, which mature into slightly abnormal myeloid cells (sometimes called granulocytes) in the bloodstream. You may also hear this type of leukaemia referred to as chronic granulocytic leukaemia (CGL). It's most common in people aged between 40 and 60.

Symptoms

The symptoms of chronic leukaemia are due to a lack of healthy white blood cells, red blood cells and platelets. Some people with chronic leukaemia - eg with stage A CLL or the chronic phase of CML - won't have any symptoms at first, and many of the symptoms are vague and seem like those of the flu. If you have any of these symptoms you should see your doctor, but it's important to remember that they may indicate other illnesses apart from chronic leukaemia. Symptoms of CML may include:

  • feeling generally tired, weak and breathless
  • itching
  • bleeding or bruising more easily
  • losing weight unintentionally
  • headaches and vision problems
  • pain in the tummy (abdominal pain), due to an enlarged spleen or liver
  • sweating at night
  • aching bones and joints, due to the pressure of cell build-up

Symptoms of CLL may include:

  • feeling very tired, weak and breathless
  • looking pale
  • fever
  • swollen lymph glands (glands in the neck, groin and under the arms)
  • having frequent infections that don't get better
  • losing weight unintentionally

Causes

There are different risk factors for CLL and CML. Some of the risk factors for developing CLL are as follows.

  • Age - the risk of developing CLL increases with age, and it's most common in people over 60.
  • Gender - men are twice as likely than women to develop CLL.

Some of the risk factors for developing CML are as follows.

  • Age - the risk of CML increases with age. It's most common in people between 40 and 60.
  • Gender - men are slightly more likely than women to develop CML.
  • Radiation exposure - you are slightly more likely to develop leukaemia is you have had radiotherapy for another cancer.
  • Chemical exposure - exposure to cancer-causing substances (carcinogens) such as benzene over a long period of time increases the risk of developing CML.

Diagnosis

Diagnosis, investigation, treatment and follow-up for people with leukaemia usually take place at specialist centres in hospitals.

People with suspected leukaemia are referred to a specialist doctor, usually a haematologist - a doctor that specialises in the treatment of blood disorders. Tests that are often carried out to investigate the type of leukaemia and how far it has progressed include:

  • blood tests (to test for abnormal cells)
  • a physical examination to check whether the spleen, lymph nodes or liver are enlarged
  • removal of bone marrow for analysis under a microscope - this is done under local anaesthetic and the bone marrow sample is taken from your hipbone (pelvis) or breastbone (sternum)
  • a lumbar puncture - the doctor draws off a small sample of the fluid from around the spine or brain with a needle for analysis
  • tissue typing - if your doctor recommends having a bone marrow transplant

Other tests that your doctor may carry out include:

  • CT (computerized tomography) scans
  • MRI (magnetic resonance imaging) scans
  • ultrasound scans
  • tissue typing - this will only be done if your doctor recommends having a bone marrow transplant
  • genetic analysis of the abnormal blood cells - to find out the type of leukaemia
  • bone scans

These tests are all very important because they help determine which treatment is best for you.

Staging for chronic leukaemia

Doctors use a system called staging to measure how far the leukaemia has progressed.

The stages for CML are as follows.

  • The chronic phase - less than 10 percent of cells in the bone marrow are immature blood cells, known as blasts. About 9 in 10 people with CML are in this phase. Symptoms are normally mild, including feeling tired.
  • The accelerated phase - between 10 and 30 percent of cells in the bone marrow are immature blast cells. Symptoms become more severe, including losing weight and having abdominal pain.
  • The blast phase - more than 30 percent of the cells in your bone marrow are immature blast cells, and these will have spread to other organs. Symptoms are more severe, including feeling very unwell and having bone pain.

Treatment

If you have been diagnosed with chronic leukaemia but have no symptoms, you may not need any treatment but will need to go to the hospital for regular check-ups. The treatment options depend on which type of chronic leukaemia you have.

Treatments for CLL

People with more advanced CLL may have the following treatments.

Chemotherapy

Chemotherapy is the first and main treatment used to destroy the abnormal white blood cells in chronic leukaemia. There are over 50 chemotherapy drugs, all with slightly different side-effects. Your doctor will give you advice about the the side-effects of your specific chemotherapy drugs, and may prescribe medicines to help reduce any side-effects.

Steroids

Steroid medicines may be prescribed at the same time as chemotherapy. They can reduce the side-effects of chemotherapy as well as treating CLL. Examples of these medicines include prednisolone and dexamethasone. These do have side-effects, and your doctor will give you further advice.

Monoclonal antibodies

Certain cancers may also respond to treatment with monoclonal antibodies. Antibodies are molecules that are made naturally by our immune systems. Their role is to seek out foreign cells and kill them off. Monoclonal antibodies (eg rituximab) can be made in a laboratory and be designed to seek out particular cells. These can bind to the CLL cells and destroy them.

Radiotherapy

Radiotherapy may be used to treat enlarged lymph nodes or spleen.

Bone marrow or peripheral stem cell transplant

Younger people with CLL may be advised to have a bone marrow or stem cell transplant. A bone marrow transplant is where healthy bone marrow - either from another person (normally a close relative) or from your own bones - is fed into your bloodstream through a drip. High doses of chemotherapy and sometimes radiotherapy are given before the transplant to destroy all the bone marrow, both abnormal and normal. This improves the chance of completely curing the leukaemia.

A peripheral stem cell transplant involves transplanting stem cells, rather than bone marrow cells. Stem cells can be collected (harvested) from your own blood or from another person and fed into your bloodstream through a drip.

Supportive therapies

These are other treatments that may be needed to control the symptoms of CLL. These treatments include having antibiotics to treat infections and blood transfusions to increase the number of red blood cells.

Treatments for CML

Treatments for CML may include using natural substances such as a protein called interferon alpha that helps the immune system fight leukaemia. Interferon alpha is normally given by an injection every day or three times a week. This medicine can have side-effects, so your doctor will give you further advice. A newer treatment is a medicine called imatinib (Glivec).

As the CML becomes more advanced, treatment may consist of mild chemotherapy (which can be in the form of tablets), bone marrow or stem cell transplantation, blood transfusion and antibiotics for infections.

Further information

Sources

  • Symptoms of leukaemia. Cancerbackup. www.cancerbackup.org.uk, accessed 5 January 2007
  • Symptoms of CML. Cancerhelp UK. www.cancerhelp.org.uk, accessed 5 January 2007
  • Cancer and its management. Souhami R & Tobias J. 5th ed. 2005. Blackwell Publishing

Related topics

This information was published by BUPA's health information team and is based on reputable sources of medical evidence. It has been peer reviewed by BUPA doctors. The content is intended for general information only and does not replace the need for personal advice from a qualified health professional.

Publication date: February 2008. Expected review date: February 2010.

 

Feedback on this factsheet

Rate this factsheet

Have you found the information in this factsheet helpful? Do take a couple of moments to give us your feedback.

We’re also currently conducting some research to help us continuously improve our health factsheets. If you live in the UK, we invite you to provide your feedback and telephone contact details. If we contact you to discuss your thoughts, it will be at a convenient time for you. For each completed telephone interview we will donate £2 to Marie Curie Cancer Care.

Click here to give us your feedback


Information you can trust

We use expert sources of medical information to research all our health information and it is checked and approved by medical professionals.

Find out more about how we produce our health information


 

   

   Rate this factsheet

Try the 'BUPA World' personality test

Are you an assertive triangle or a creative squiggle?

Monthly newsletter

The latest health information and news from BUPA

 back to top